Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Wake Forest University · Vancouver General Hospital · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,362
total citations
- FWCI
- 80.81
- Percentile
- 100%
- References
- 29
Citations per year
Authors
11Topics & keywords
Topics
Keywords
- Benralizumab
- Medicine
- Exacerbation
- Placebo
- Asthma
- Eosinophilia
- Mepolizumab
- Clinical endpoint
No related works found for this paper.